AJP - Heart Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 279: H1571-H1578, 2000;
0363-6135/00 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keith, I. M.
Right arrow Articles by Ekman, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keith, I. M.
Right arrow Articles by Ekman, R.
Vol. 279, Issue 4, H1571-H1578, October 2000

Three-week neonatal hypoxia reduces blood CGRP and causes persistent pulmonary hypertension in rats

I. M. Keith1, S. Tjen-A-Looi1, H. Kraiczi2, and R. Ekman2

1 Department of Comparative Biosciences, School of Veterinary Medicine, University of Wisconsin, Madison, Wisconsin 53706; and 2 Section of Experimental Neuroscience, Institute of Clinical Neuroscience, University of Göteborg, Mölndal's Hospital, S-43180 Mölndal, Sweden


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

To increase understanding of persistent pulmonary hypertension, we examined chronic pulmonary effects of hypoxia at birth and their relationships with immunoreactive levels of the potent vasodilator, calcitonin gene-related peptide (CGRP). Rats were born in 10% hypobaric hypoxia, where they remained for 1-2 days, or in 15% hypoxia, where they remained for 21 days. All were then reared in normoxia for 3 mo followed by reexposure to 10% hypoxia for 7 days (Hright-arrowH) or continued normoxia (Hright-arrowN); age-matched normoxic rats were hypoxic for the last 7 days (Nright-arrowH) or normoxic throughout (Nright-arrowN). Results are as follows. Pulmonary arterial pressure (PPA) in 10% Hright-arrowN rats was normal at the end of the experiment (13 wk), but in rats reexposed to hypoxia (Hright-arrowH), pressure rose to 19% above Nright-arrowH controls. In 15% Hright-arrowN rats, PPA remained high, similar to that of Nright-arrowH rats, and increased further by 40% on reexposure (Hright-arrowH). Medial thickness of small pulmonary arteries in 10% Hright-arrowH rats also increased by 40% over Nright-arrowH controls and was equally high in 15% Hright-arrowN and Hright-arrowH rats. In Nright-arrowH rats from both experiments, right ventricular hypertrophy index (RVH) was increased after hypoxia at 15-16 wk. Also, in the 15% study, RVH remained elevated in Hright-arrowN rats and increased in Hright-arrowH rats by 19% above Nright-arrowH controls. Blood CGRP was reduced by neonate and adult hypoxia, and hypoxic reexposure (Hright-arrowH) further lowered blood CGRP in the 15% but not 10% study. Declining left ventricular blood CGRP correlated highly with logarithmically increasing PPA in the 15% study (r = -0.81, P = 0.000). In conclusion, 1) short perinatal exposure to 10% O2 exacerbated pulmonary hypertension with hypoxia later in life, 2) 15% O2 at birth and for 21 days caused persistent pulmonary hypertension and exacerbation with reexposure, and 3) PPA correlated highly with declining blood CGRP levels in the 15% study.

hypoxic sensitization; persistent hyperventilation; right ventricular hypertrophy; calcitonin gene-related peptide


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

PERSISTENT PULMONARY HYPERTENSION (PPH) of the newborn is a clinically challenging lung condition, and its etiology is poorly understood. These patients are usually full-term or postterm infants who have had perinatal asphyxia, meconium aspiration, diaphragmatic hernia, pneumonia, or sepsis (1, 30), all of which could interfere with pulmonary oxygenation or gas exchange. In the United States the incidence of PPH varies between 0.07 and 2.3% of live births, accounting for ~1% of admissions to neonatal intensive care units (42). Despite aggressive management with hyperventilation, fluids, and vasodilators, mortality is as high as 34-60% (1, 9, 10, 21). These lung disorders together constitute a group in great need of further understanding of the mechanism(s) associated with pulmonary hypertension (PH) and subsequent development of effective treatment.

In addition to newborns, PH affects animals and humans of all ages. Aside from pathologically elevated pulmonary arterial pressure (17), PH is frequently associated with pulmonary vascular remodeling and tissue edema and right ventricular hypertrophy (16). Airway hypoxia is probably the most common cause of PH. It occurs at high altitude and can also result from hypoventilation (e.g., sleep apnea) and restrictive lung disorders or inflammatory processes that interfere with airway oxygenation. Among these disorders are respiratory distress syndrome among infants, adult respiratory distress syndrome, and chronic obstructive pulmonary disease among adults. Moreover, infants who have died from sudden infant death syndrome carry markers suggestive of airway hypoxia and PH (40).

Although the pulmonary vasculature is relatively responsive to a variety of vasoactive agents, it appears that an imbalance between constrictor and dilator peptides may contribute to the pulmonary vasoconstriction and hypertension that occurs under hypoxic airway conditions. For example, the neuropeptide calcitonin gene-related peptide (CGRP) effectively dilates precontracted systemic and pulmonary arteries in vitro (26, 27) utilizing CGRP-1 receptors (2, 13, 38, 43); it is one of the most potent endogenous vasodilators known to date (41, 43). CGRP has one endothelium-dependent mode of action (6) and also dilates some systemic arteries and the pulmonary circulation, independent of endothelial factors such as nitric oxide (27, 35). Our laboratory previously shown that endogenous CGRP has an essential protective role in hypoxia-induced PH (HPH) (37, 38) and that circulating levels of immunoreactive CGRP are reduced in rats with HPH, thus allowing constrictors such as endothelin (ET)-1 to act unopposed (14, 39). Vasoconstriction is further enhanced by increased ET-1 synthesis in hypoxia (24). However, available CGRP receptors remain in the hypoxic lung vasculature (as indicated by increased CGRP binding) (25), allowing for protection by exogenous CGRP (18).

CGRP is a 37-amino acid polypeptide hormone produced by tissue-specific, alternative RNA splicing of the calcitonin gene (3) and is expressed in sensory neurons. CGRP-like immunoreactivity is localized in nerve fibers of the airway mucosa and around vascular smooth muscle (4, 24, 37). Moreover, CGRP and its mRNA have been localized in the perikarya of intrapulmonary ganglia and in neuroendocrine cells of the airway epithelium (4, 19, 26), indicating CGRP synthesis and storage in these cells. These neuroendocrine epithelial cells, both solitary and clustered, have been shown to function as airway O2 sensors that respond to altered airway O2 content (23, 37, 44) by modulating local pulmonary vascular tone (37, 38). CGRP is therefore strategically localized, interconnecting neuroendocrine cells, airway epithelium, and local vasculature in a local microcircuit (37).

Because of a strong clinical need for further understanding of peptidergic mechanisms associated with neonate PH, we established a neonate hypoxia model of PPH in rats based on limited prior information (5, 12, 20, 32). We characterize here the chronic adult PH effects of hypoxic exposure at birth and examine their relationships with levels of immunoreactive circulating CGRP.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Experimental protocol. Pregnant Sasco Sprague-Dawley rats (primipara) were kept in a hypobaric hypoxia chamber (Biotron, Univ. of Wisconsin) from gestational day 16 (term = 21 days). In experiment I they gave birth at a barometric pressure (PB) of 380 mmHg [equivalent to inspired O2 fraction (FIO2) 10%]. However, because of high incidence of neonate deaths in the first week after birth in hypoxia (85%) with the use of 10% O2, subsequent pups were placed with their mothers in normobaric normoxia 1-2 days postpartum. In experiment II pups were born at a PB of 520 mmHg (equivalent to FIO2 15%) and remained in hypoxia for 21 days. Survival rate was similar to that of pups born in normoxia (96.5%). Pups from both experiments were then reared in normoxia for 3 mo. At that time (12 and 15 wk of age, respectively), one group from each experiment was reexposed to hypobaric hypoxia equivalent to FIO2 at 10% for 7 days (Hright-arrowH group) while another group remained in normoxia (Hright-arrowN group). Moreover, in both experiments, age-matched rats of normoxic mothers were born and raised in normoxia (ambient air, ~21% O2) under similar conditions regarding cage size, lighting, food, and water. These control rats were exposed to hypobaric hypoxia for the first time during the last 7 days (Nright-arrowH group) or were normoxic throughout (Nright-arrowN group).

Numbers of rat pups were adjusted by culling to achieve similar numbers per group and mother within experiments. In experiment I, 12 normoxic pups and 12 surviving hypoxic pups were separated from their mothers on day 1 or 2 after birth and raised by 4 normoxic and 4 hypoxic adoptive mothers, respectively. To achieve identical sample sizes (3 pups per mother), hypoxic pups were moved from larger litters to mothers with only one or two young, and normoxic pups were culled. Because of additional deaths among rats born in hypoxia, these numbers were further reduced from six pups per group to four and five per group. In experiment II, to avoid bias by maternal factors, 16 normoxic and 16 hypoxic pups were switched on day 2 after birth between 4 normoxic and 4 hypoxic adoptive mothers, respectively, resulting in 8 pups per treatment group (4 per mother). A total of 21 and 32 pups were used for experiments I and II, respectively. All rats were treated and housed humanely according to an animal care protocol approved by the University of Wisconsin-Madison Research Animal Resources Center and the Animal Welfare Act (assurance no. A-3368-01).

Arterial blood pressure measurements and tissue processing. At the end of each experiment, rats from the hypobaric chamber were transferred to the laboratory and placed temporarily in a normobaric chamber under continuous flow of 10% O2 in N2. Before blood pressure recording, rats were anesthetized with pentobarbital sodium (42 mg/kg ip), and mean systemic pressure was recorded from the femoral artery while rats were spontaneously breathing. Blood was then drawn from the arterial cannula and heparinized for blood-gas analysis [arterial PO2 (PaO2) and arterial PCO2 (PaCO2)] by use of an ABL 500 analyzer. Thereafter, the trachea was cannulated for ventilation with room air (normoxic rats) or 10% O2 (hypoxic rats) with the use of a Harvard rodent ventilator set at 1.75-ml tidal volume and a respiratory rate of 70 breaths/min. A midline 2-cm-long thoracotomy was performed, and mean right ventricular pressure (PRV) was recorded through a 20-gauge angiocath catheter inserted into the right ventricle (RV) just beneath the pulmonary arterial (PA) root. The cannula was then advanced into the PA as previously described (38) to record mean PA pressure (PPA). The thymus was gently moved to the side to expose the PA and confirm correct placement of the catheter. All blood pressure measurements utilized a Statham pressure transducer and a Gould recorder, and mean pressures were obtained using the "mean" function on the Gould recorder.

Effluent blood from the lungs was drawn from the left ventricle (LV) into 10-ml syringes pretreated with EDTA (10 µl of 10% EDTA/ml blood; no. 2670, Ricca Chemical) and Trasylol (200 kallikrein-inactivating unit/ml blood; no. A-1153, Sigma), transferred to glass tubes, and placed briefly on ice until centrifugation (804 g at +4°C for 20 min). The plasma was collected, lyophilized, and stored at -70°C for later analysis of peptide levels; plasma and blood volume measurements were also used to determine hematocrit.

Lungs were then perfused with heparinized saline, removed, and weighed. One 3-mm-thick transverse slice was sampled from the midregions of the left lobe and the right lower (diaphragmatic) lobe for histochemistry and morphometry, and the remainder was weighed, snap frozen, and stored at -70°C for subsequent peptide assays. The lung pellet remaining after tissue peptide extraction for radioimmunoassay was lyophilized and used for dry weight. Hearts were isolated and fixed in 10% buffered Formalin; they were later blotted, dissected, and weighed while moist. The weight ratio of RV to LV plus septum (S) [RV/(LV + S)] was used to evaluate RV hypertrophy.

Radioimmunoassay. Lungs were partially thawed, diced with a razor blade into 3 × 3-mm cubes, and homogenized (Tissuemizer Mark II, Tekmar). Lung tissue peptides were extracted by boiling tissue homogenates in saline for 15 min, followed by centrifugation (2,300 g at +4°C for 30 min) and collection of supernatants. The lung pellets were boiled again for 15 min, using 0.5 M acetic acid, followed by centrifugation. For each lung, the combined supernatants were stored lyophilized until assay. Radioimmunoassays for CGRP were performed in duplicates on lung extracts and LV plasma according to previously published methods (11, 37, 38). As lung water and dry tissue mass are elevated in hypoxic rats, thereby significantly increasing lung weight, peptide levels are expressed as picomoles per whole lung instead of wet weight to avoid falsely low values. This was done under the assumption that the amount of CGRP containing lung parenchyma (not including edema and increased connective tissue) was similar between groups as body weights are similar (Table 1). Moreover, because hematocrit was increased in hypoxic rats, peptide levels are expressed as picomoles per liter of blood to avoid differences due to reduced plasma volume (38).

                              
View this table:
[in this window]
[in a new window]
  		Table 1.   Body weights of rats at the end of experiments

Morphometric evaluation of pulmonary vascular medial thickness index. We used histological sections of noninflated, noninjected routinely fixed lung samples (7) stained with Miller elastin stain (28) to determine medial thickness index on naturally expanded, cross-sectioned circular pulmonary vessels ranging from 50 to 100 µm in outer diameter. The selected vessels were presumed to be arteries because of their round shapes and distinct internal and external elastic laminae. The surface area of the cross-sectioned media was measured in each randomly selected vessel as outlined by the internal and external laminae. Average vessel diameter (2 × radius; 2r) was calculated from the total pixel area inside the circumference of the external lamina of the vessel as follows using the correction factor: 3.12 pixels = 1 µm, pixel area = 3.122 = 9.73, pixel area/9.73 = µm area. Total pixel area is pi r2; r2 = pixel area/pi , and r (in µm) = the square root of pixel area/9.73 · pi . Average diameter per vessel is 2r. Medial area was then normalized for each vessel by dividing by average diameter of that vessel. This method is more precise than direct measurement and averaging of the medial thickness and diameter, respectively, in two perpendicular sites, as previously employed (17, 36, 38). For the above measurements, we applied an Image Pro Plus morphometry software program to vessel images imported into a Gateway 486 computer using a Nikon Labophot microscope and a high-resolution color camera. A minimum of 10 vessels per rat was measured, and the individual means were used to calculate the group means.

Statistical analysis. Results are expressed throughout as group means ± SE. Data were evaluated by use of ANOVA followed by Student-Newman-Keuls test for multiple comparisons. Where so indicated, Student's t-test for unpaired data was used to compare a specific test group with its matched control. The latter test was used mostly to detect trends toward differences that might have proven significant with larger sample sizes in the Student-Newman-Keuls test.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Body weights did not differ significantly between any two treatment groups among either 10% or 15% rats at the end of each experiment (Table 1); overall mean body weight among rats was 382 g. However, males were, on average, 70% heavier than females (492 ± 12 vs. 290 ± 9 g). Sex composition was 52% females and 48% males and was similar within individual treatment groups.

Blood gas analysis in the 15% O2 experiment confirmed that rats exposed for the first time to hypoxia at the end of the experiment (Nright-arrowH) had lower PaO2 compared with Nright-arrowN controls (Table 2). However, in Hright-arrowN rats, PaO2 was above Nright-arrowN controls, suggesting hyperventilation in the former. Similarly, PaCO2 was lower in all hypoxia groups compared with normoxic controls, supporting expected hyperventilation in these groups as well as the Hright-arrow N rats.

                              
View this table:
[in this window]
[in a new window]
  		Table 2.   Blood gases in anesthetized, spontaneously breathing rats from the 15% study at the end of experiments

Mean PPA among rats born in a hypobaric O2 environment (equivalent to 10% inhaled O2) and maintained in this environment for only 1-3 days (Fig. 1A), hereafter referred to as 10% rats (Hright-arrowN group; n = 4), was at normoxic control levels (Nright-arrowN; n = 6) at the end of the experiment over 3 mo later. However, when reexposed to 10% hypoxia after 3 mo (Hright-arrowH group; n = 5), these rats developed elevated PPA (19% increase) compared with age-matched rats born and maintained in normoxia and exposed to hypobaric hypoxia for the first time at age 15 wk (Nright-arrowH group; n = 6). Furthermore, mean PPA among rats born in a hypobaric O2 environment equivalent to 15% inhaled O2 and maintained in this environment for 21 days (Fig. 1B), hereafter referred to as 15% rats, remained elevated after over 3 mo of normoxia (Hright-arrowN; n = 8) compared with controls (Nright-arrowN; n = 8), indicating PPH. Additionally, PPA levels in rats reexposed to hypoxia (Hright-arrowH; n = 7) rose to 40% above those of age-matched rats exposed to hypoxia for the first time (Nright-arrowH; n = 8). Mean RV pressures followed closely the same pattern as PPA (Fig. 1, A and B).


View larger version (43K):
[in this window]
[in a new window]
  		Fig. 1.   Open-chest pulmonary arterial (PA) and right ventricular (RV) pressures in 10% rats (A) and 15% rats (B) and age-matched treatment groups. H, hypoxia; N, normoxia. (For more detailed descriptions of rat groups, see MATERIALS AND METHODS.) * Significantly different from PA pressure (PPA) of all other groups. dagger  Not different from other group marked the same. dagger dagger Not different from other group marked the same. ** Not significantly different from group marked the same but different from dagger dagger . , Significantly different from RV pressures of all other groups. (Student-Newman-Keuls test at P <=  0.05.)

Medial thickness index among 10% rats born in hypoxia (Fig. 2A) was normal after 3 mo (Hright-arrowN) but was markedly elevated (53% increase) after hypoxic reexposure (Hright-arrowH) compared with age-matched rats exposed for the first time (Nright-arrowH). On the other hand, among 15% rats (Fig. 2B), medial thickness index remained greater after 3 mo (Hright-arrowN) compared with age-matched normoxic controls (Nright-arrowN). These levels were similar to those of reexposed 10% and 15% rats (Hright-arrowH). Hypoxia for the first time (7 days) at the end of the experiment (Nright-arrowH) did not increase medial thickness index significantly in either experiment.


View larger version (47K):
[in this window]
[in a new window]
  		Fig. 2.   Pulmonary vascular medial thickness index (medial area/outer diameter, in µm) in 10% rats (A) and in 15% rats (B) and age-matched treatment groups (for more detailed descriptions of rat groups, see MATERIALS AND METHODS). * Significantly different from all other groups. dagger  Not different from other groups marked the same. dagger dagger Not different from other groups marked the same. dagger  and dagger dagger are significantly different from one another. (Student-Newman-Keuls test at P <=  0.05.)

RV weight index among the 10% rats (Fig. 3A) was normal after 3 mo (Hright-arrowN vs. Nright-arrowN) and was equally elevated in the reexposed rats (Hright-arrowH) and those exposed only after 3 mo (Nright-arrowH). On the other hand, RV weight index of the 15% rats (Fig. 3B) remained high after 3 mo (Hright-arrowN) at the index of age-matched rats exposed for the first time (Nright-arrowH) and was further elevated by reexposure (Hright-arrowH, 23%).


View larger version (49K):
[in this window]
[in a new window]
  		Fig. 3.   RV weight index [RV/(left ventricle + septum)] in 10% rats (A) and in 15% rats (B) and age-matched treatment groups (for more detailed descriptions of rat groups, see MATERIALS AND METHODS). * Significantly different from all other groups. dagger  Not different from other groups marked the same. dagger dagger Not different from other groups marked the same. dagger  and dagger dagger are significantly different from one another. (Student-Newman-Keuls test at P <=  0.05.)

Hematocrit among both 10% and 15% rats was normal after 3 mo (Hright-arrowN; 0.50 ± 0.06 and 0.69 ± 0.03, respectively) compared with controls (Nright-arrowN; 0.59 ± 0.03 and 0.67 ± 0.00, respectively). However, hematocrit was equally elevated after hypoxic reexposure (Hright-arrowH; 0.77 ± 0.04 and 0.81 ± 0.02, respectively) and in age-matched rats after the first hypoxic exposure as adults (Nright-arrowH; 0.77 ± 0.04 and 0.81 ± 0.02, respectively).

Lung tissue levels of immunoreactive CGRP (Fig. 4) were not significantly different between the same treatment groups in the 10% and 15% experiments. Thus, in both experiments, the Hright-arrowH and Nright-arrowH rats had significantly higher lung CGRP levels after 3 mo of normoxia compared with Hright-arrowN rats but did not differ from Nright-arrowN controls. Although the means for Hright-arrowN rats were 41 and 38%, respectively, below those of Nright-arrowN controls, these differences may indicate trends but were not statistically significant.


View larger version (43K):
[in this window]
[in a new window]
  		Fig. 4.   Lung tissue calcitonin gene-related peptide (CGRP) levels in 10% rats (A) and in 15% rats (B) at the end of experiments. * Significantly lower than Hright-arrowH and Nright-arrowH groups but not different from Nright-arrowN by use of the Student-Newman-Keuls test at P <=  0.05. dagger  Not different from other groups marked the same.

LV blood levels of immunoreactive CGRP (Fig. 5) were significantly lower in all three hypoxic groups of both experiments compared with their respective normoxic control group (Nright-arrowN). The 10% Hright-arrowN group (Fig. 5A) had levels 85% below those of Nright-arrowN rats, and, among 15% Hright-arrowN rats (Fig. 5B), levels were 46% lower than normoxic controls. Among 15% rats, levels were further reduced to 69% below Nright-arrowN rats on reexposure to hypoxia (Hright-arrowH). Regression analysis of the 10% study data revealed no significant correlation between blood CGRP levels and PPA. Regression analysis of the entire 15% data set (Fig. 6) indicated a highly significant, strong negative correlation between PPA and blood CGRP levels (r = -0.81, P = 0.000), indicating that mean PPA increased exponentially with declining LV blood CGRP.


View larger version (33K):
[in this window]
[in a new window]
  		Fig. 5.   Levels of immunoreactive CGRP in left ventricular blood among 10% rats (A) and 15% rats (B) and age-matched treatment groups. * Significantly higher than all other groups. dagger  Not different from other group marked the same. (Student-Newman-Keuls test at P <=  0.05.) , Lower than Nright-arrowH group at P = 0.013; black-triangle, lower than Hright-arrowN group (P = 0.005) (Student's t-test.)



View larger version (15K):
[in this window]
[in a new window]
  		Fig. 6.   Regression analysis of the relationship between PPA and blood levels of immunoreactive CGRP within the 15% data set. Circles indicate individual data points. There was a highly significant curvilinear, exponential increase in PPA that correlated with declining CGRP levels; r = -0.81, P = 0.000.

Mean systemic arterial pressure, only measured in experiment II, was reduced among Nright-arrowH rats (80 ± 6 mmHg) and unchanged in Hright-arrowH rats (115 ± 38 mmHg) and Hright-arrowN rats (92 ± 14 mmHg) compared with Nright-arrowN controls (116 ± 38 mmHg).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Our results indicate that hypoxia in the perinatal period has profound effects on the future lung health of an individual and may predispose one for PH later in life. It is particularly notable that 10% hypoxia perinatally and for just 1-2 days postpartum could cause elevated PPA on hypoxic reexposure as adults. This seems especially significant considering these data were collected mostly from survivors who would be expected to have a high level of resistance to hypoxia. Whereas a more moderate hypoxia of 15% O2 allowed most pups to survive, birth and rearing in this environment for 21 days resulted in PPH, as measured more than 3 mo later, and more severe HPH on hypoxic reexposure than present among those rats exposed for the first time. Using similar protocols with Wistar albino rats and 1-wk neonate hypoxia (10%), Hampl and Herget (12) found PPA equally elevated in Nright-arrowH and Hright-arrowH rats. However, 2 wk after a repeat of hypoxia, isolated lungs showed heightened reactivity to acute hypoxia and increased perfusion pressure. Moreover, an exaggerated response to the alkaloid monocrotaline was demonstrated by Caslin et al. (5) and King et al. (20) in adult rats that were exposed to hypoxia neonatally. This response was indicated by more rapid and pronounced pulmonary vascular muscularization and higher RV hypertrophy index (RVH) (both associated with PH) compared with monocrotaline controls not exposed to neonatal hypoxia. These changes support our findings of neonatal hypoxia predisposing for exacerbated PH on an agonistic stimulus later in life. However, neonate hypoxia in rats has also been found to attenuate in vitro PA responses to hypoxia (12) or agonists such as norepinephrine and potassium chloride (32). This suggests that a whole animal approach is advantageous for summarizing the effects of neural, humoral, and other factors on hypoxic stimuli.

The exacerbated PH in Hright-arrowH rats did not result indirectly from raised systemic or left atrial pressure, as there was no difference in systemic pressure between Hright-arrowH and Nright-arrowN groups (115.2 ± 4.83 and 116 ± 3.84 mmHg, respectively). Altered pulmonary pressures could potentially arise from increased cardiac output or a rise in left atrial pressure. However, cardiac output in rats is not increased by hypoxia (6), and an independent rise in left atrial pressure alone is not expected. We thus speculate that the hypoxic pressor response is primarily intrapulmonary, as suggested long ago by Daly and Hebb (8) and Laros (22).

Hypoxic exposure at the end of each experiment (Nright-arrowH), when rats were adult, resulted in the typical elevation of PPA, PRV, hematocrit, medial thickness, and RV weight, as previously reported (15-17), although the medial thickness remodeling was not statistically significant after 1 wk of hypoxia. The PPH in 15% Hright-arrowN rats was accompanied by increased medial thickness and RV weight ratio as expected, in contrast to normal values in 10% Hright-arrowN rats, which had normal PPA. Accelerated smooth muscle changes in the pulmonary vasculature by monocrotaline (20), as previously mentioned, suggest increased vascular reactivity to several types of agents. The differences in vascular reactivity to hypoxia, reported by several laboratories, likely reflect differences in animal age and, perhaps more importantly, a difference in rat strains. We know, for example, that some strains, e.g., Hilltop rats, are highly sensitive to hypoxia (31) and that fawn-hooded rats develop spontaneous PH (34). The strain used here (Sasco Sprague-Dawley) is considered moderately reactive and appears to be less responsive to hypoxia than the Wistar rat (5, 12, 20, 32).

Normoxic rats with PPH (15% Hright-arrowN) maintained high PaO2 and normal hematocrit through hyperventilating (PaCO2 reduced 28% below normal). Therefore, airway hypoxia is not likely the cause of their elevated PPA. This could potentially result from chronically reduced CGRP levels noted in LV blood. Hyperventilation by adult (50-day-old) normoxic rats born in hypoxia was also noted by Okubo and Mortola (29).

In both experiments, lung tissue CGRP was higher in the Hright-arrowH and Nright-arrowH rats but not in Nright-arrowN rats compared with the Hright-arrowN group. However, there was no significant measurable difference between Hright-arrowH, Nright-arrowH, and Nright-arrowN groups. Previous reports by us and others (17, 36) suggest that lung CGRP may increase during chronic hypoxia in adult rats, but levels vary between studies. The primary site for the increased lung CGRP is believed to be airway neuroendocrine cells (36). Although the lung dynamics of CGRP in hypoxia are unknown, reduced LV blood levels as seen by us in the Hright-arrowH, Hright-arrowN, and Nright-arrowH rats could result from impaired release to the blood stream from intrapulmonary sources.

Among our rats exposed to perinatal hypoxia, not only did PA and RV pressures remain persistently high but so did medial thickness and RV weight. These PH hallmarks did not disappear during more than 3 mo of normoxia, indicating PPH in the presence of normal PaO2 and hematocrit. Furthermore, in experiment II, the substantial reduction in LV blood CGRP among the Hright-arrowN rats may indicate a causal relationship between reduced bioavailability of CGRP to its vascular receptors and the chronically increased PPA. In fact, blood CGRP levels among the rats from all groups in experiment II were negatively correlated with PA pressures. Specifically, the Hright-arrowH group had the lowest levels of circulating CGRP and the highest PPA, and among Hright-arrowN rats, PPH was associated with significantly reduced CGRP levels after 3 mo of recovery in normoxia. These CGRP levels were similar to those of age-matched rats newly exposed to hypoxia (Nright-arrowH).

The foregoing results supplement the many previous observations in our laboratory implicating reduced endogenous blood CGRP levels in HPH (17, 18, 37-39). The 10% Hright-arrowN group is an exception in that blood CGRP levels remained extremely low 3 mo posthypoxia, whereas PPA was normal. The low blood CGRP levels could have resulted from the relatively low lung levels in this group, suggesting reduced CGRP availability and/or impaired synthesis. The normal PPA in the 10% Hright-arrowN group might be explained by the fact that this was a small group (n = 4) composed of survivors of 10% neonate hypoxia, perhaps subjected to natural selection. A redundant vasodilator such as adrenomedullin, a member of the CGRP superfamily, could potentially be the alternative depressor agent among these surviving rats, as it may also bind to the CGRP-1 receptor (13); we believe this needs to be examined further. Small sample sizes in the 10% experiment may explain why we found few significant differences between groups overall and no significant correlation between blood CGRP and PPA in that study.

We have previously shown prevention and reversal of HPH with exogenous alpha -rat CGRP infused chronically into the pulmonary circulation of awake, unrestrained rats (18, 38). On the other hand, depletion of sensory CGRP with capsaicin resulted in exaggerated PPA and RVH in hypoxia and augmented PA medial thickness in both normoxia and hypoxia (37). Moreover, we infused the selective CGRP-1 receptor antagonist CGRP-(8-37) and the nitric oxide synthase inhibitor NG nitro-L-arginine methyl ester (L-NAME) into the closed circulation of in vitro lung preparations precontracted with potassium chloride (38). CGRP-(8-37) blocked vasodilation by exogenous CGRP, but L-NAME did not, suggesting that CGRP may act directly on the pulmonary vascular smooth muscle via CGRP-1 receptors in an endothelium-independent fashion, probably targeting resistance vessels. This previous information, taken together with results from the present research, supports a role of CGRP in HPH. We conclude that exposure to 15% perinatal hypoxia lowers blood CGRP levels in association with PPH and predisposes for PH later in life.


    ACKNOWLEDGEMENTS

We thank Reneé Sandler, Jie Jin, Brian Teunissen, and Rita Persson for technical assistance. Hypobaric hypoxia exposures were performed at the Biotron at the University of Wisconsin-Madison.


    FOOTNOTES

This study was supported by American Heart Association of Wisconsin Grant 93-GS-60.

Present address of S. Tjen-A-Looi: Dept. of Medicine, College of Medicine, Medical Sciences I Rm. C240, Univ. of California, Irvine, CA 92697 (E-mail: stjenalo{at}uci.edu).

Address for reprint requests and other correspondence: I. M. Keith, Dept. of Comparative Biosciences, School of Veterinary Medicine, Univ. of Wisconsin, 2015 Linden Drive West, Madison, WI 53706 (E-mail: keithi{at}svm.vetmed.wisc.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 26 February 1999; accepted in final form 24 April 2000.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Abu-Osba, YK. Treatment of persistent pulmonary hypertension of the newborn: update. Arch Dis Child 66: 74-77, 1991[ISI][Medline].

2.   Aiyar, N, Rand K, Elshourbagy NA, Zeng Z, Adamou JE, Bergsma DJ, and Li Y. cDNA encoding the calcitonin gene-related peptide type 1 receptor. J Biol Chem 271: 11325-11329, 1996[Abstract/Free Full Text].

3.   Amara, SG, Jonas V, Rosenfeld MG, Ong ES, and Evans R. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 298: 240-244, 1982[Medline].

4.   Cadieux, A, Springall DR, Mulderry PK, Rodrigo J, Ghatei MA, Terenghi G, Bloom SR, and Polak JM. Occurrence, distribution and ontogeny of CGRP immunoreactivity in the rat lower respiratory tract: effect of capsaicin treatment and surgical denervations. Neuroscience 19: 605-637, 1986[ISI][Medline].

5.   Caslin, A, Heath D, and Smith P. Influence of hypobaric hypoxia in infancy on the subsequent development of vasoconstrictive pulmonary vascular disease in the Wistar albino rat. J Pathol 163: 133-141, 1991[ISI][Medline].

6.   Chen, CF, Chien CT, and Chiu IS. Cardiovascular effects of endothelin in chronic hypoxic rats. Chin J Physiol 35: 95-104, 1992[Medline].

7.   Colpaert, C, Hogan J, Stark AR, Roberts D, and Kozakewich H. Increased muscularization of small pulmonary arteries in preterm infants of diabetic mothers: a morphometric study in non-inflated, non-injected, routinely fixed lungs. Pediatr Pathol Lab Med 15: 689-705, 1995[ISI][Medline].

8.   Daly, I, and Hebb I. Pulmonary and bronchial vascular system. Their reaction undercontrolled conditions of ventilation and circulation. London: Arnold, 1966.

9.   Davis, JM, Spitzer AR, Cox C, and Fox WW. Predicting survival in infants with persistent pulmonary hypertension of the newborn. Pediatr Pulmonol 5: 6-9, 1988[ISI][Medline].

10.   Fox, WW, and Duara S. Persistent pulmonary hypertension of the neonate: diagnosis and clinical management. J Pediatr 103: 505-508, 1983[ISI][Medline].

11.   Grunditz, T, Ekman R, Håkanson R, Rerup C, Sundler F, and Uddman R. Calcitonin gene-related peptide in thyroid nerve fibers and C cells: effects on thyroid hormone secretion and response to hypercalcemia. Endocrinology 119: 2313-2323, 1986[Abstract].

12.   Hampl, V, and Herget J. Perinatal hypoxia increases hypoxic pulmonary vasoconstriction in adult rats recovering from chronic exposure to hypoxia. Am Rev Respir Dis 142: 619-624, 1990[ISI][Medline].

13.   Han, ZQ, Coppock HA, Smith DM, Van Noorden S, Makgoba MW, Nicholl CG, and Legon S. The interaction of CGRP and adrenomedullin with a receptor expressed in rat pulmonary vascular endothelium. J Mol Endocrinol 18: 267-272, 1997[Abstract].

14.   Helset, E, Kjaelve J, Bjaertnes L, and Lundberg JM. Acute alveolar hypoxia increases endothelin-1 release but decreases release of calcitonin gene-related peptide in isolated perfused rat lungs. Scand J Clin Lab Invest 55: 369-376, 1995[ISI][Medline].

15.   Hultgren, HN. High altitude pulmonary edema. In: Lung Water and Solute Exchange, edited by Staub N.C.. New York: Dekker, 1978, vol. 7, chapt. 15, p. 437-469.

16.   Hunter, C, Barer GR, Shaw JW, and Clegg EJ. Growth of the heart and lungs in hypoxic rodents: a model of human hypoxic disease. Clin Sci Mol Med 46: 375-391, 1974[ISI][Medline].

17.   Keith, IM, and Ekman RE. Dynamic aspects of regulatory peptides in chronic hypoxic pulmonary hypertension. Exp Lung Res 18: 205-224, 1992[ISI][Medline].

18.   Keith, IM, Ekman R, Kraiczi H, and Sandler R. CGRP treatment of chronic hypoxia-induced pulmonary hypertension in rats (Abstract). FASEB J 9: A601, 1995.

19.   Keith, IM, Pelto-Huikko M, Schalling M, and Hökfelt T. Calcitonin gene-related peptide and its mRNA in pulmonary neuroendocrine cells and ganglia. Histochemistry 96: 311-315, 1991[ISI][Medline].

20.   King, AP, Smith P, and Heath D. Ultrastructure of rat pulmonary arterioles after neonatal exposure to hypoxia and subsequent relief and treatment with monocrotaline. J Pathol 177: 71-81, 1995[ISI][Medline].

21.   Krummel, TM, Greenfield LJ, Kirkpatrick BV, Mueller DG, Kirkering KW, Ormazabal M, Napolitano A, and Salzburg AM. Alveolar-arterial oxygen gradients versus the pulmonary insufficiency index for predicition of mortality in ECMO candidates. J Pediatr Surg 19: 380-384, 1984[ISI][Medline].

22.   Laros, CD. Local chemical regulation of the flow resistance in the bronchial tree and pulmonary circulation. Respiration 28: 120-136, 1971[ISI][Medline].

23.   Lauweryns, JM, Cokelaere M, Deelersnijder M, and Liebens M. Intrapulmonary neuroepithelial bodies in newborn rabbits. Influence of hypoxia, hyperoxia, hypercapnia, nicotine, reserpine, L-DOPA and 5-HTP. Cell Tissue Res 182: 425-440, 1977[ISI][Medline].

24.   Li, H, Chen SJ, Chen YF, Meng QC, Durand S, Oparil S, and Elton TS. Enhanced endothelin-1 and endothelin receptor gene expression in chronic hypoxia. J Appl Physiol 70: 331-341, 1991[Abstract/Free Full Text].

25.   Mannan, MM, Springall DR, Enard C, Moradoghli-Haftvani A, Eddahibi S, Adnot S, and Polak JM. Decreased endothelium-dependent pulmonary vasodilator effect of calcitonin gene-related peptide in hypoxic rats contrasts with increased binding sites. Eur Respir J 8: 2029-2037, 1995[Abstract].

26.   Martling, CR, Saria A, Fisher JA, Hökfelt T, and Lundberg JM. Calcitonin gene-related peptide and the lung: neuronal co-existence with substance P, release by capsaicin, and vasodilatory effect. Regul Pept 220: 125-139, 1994.

27.   McCormack, DG, Mak JC, Coup MO, and Barnes PJ. Calcitonin gene-related peptide vasodilation of human pulmonary vessels. J Appl Physiol 67: 1265-1270, 1989[Abstract/Free Full Text].

28.   Miller, PJ. An elastin stain. Med Lab Technol 28: 148-149, 1971[ISI][Medline].

29.   Okubo, S, and Mortola JP. Control of ventilation in adult rats hypoxic in the neonatal period. Am J Physiol Regulatory Integrative Comp Physiol 259: R836-R841, 1990[Abstract/Free Full Text].

30.   O'Toole, SJ, Irish MS, Holm BA, and Glick PL. Pulmonary vascular abnormalities in congenital diaphragmatic hernia. Clin Perinatol 23: 781-794, 1996[ISI][Medline].

31.   Ou, LC, Salceda S, Schuster SJ, Dunnack LM, Brink-Johnsen T, Chen J, and Leiter JC. Polycythemic responses to hypoxia: molecular and genetic mechanisms of chronic mountain sickness. J Appl Physiol 84: 1242-1251, 1998[Abstract/Free Full Text].

32.   Packer, CS, Bennie RE, Powell DR, and Rhoades RA. Neonatal hypoxia: long term effects on pulmonary arterial muscle. Respir Physiol 96: 213-229, 1994[ISI][Medline].

33.   Samuelson, UE, and Jernbeck J. Calcitonin gene-related peptide relaxes porcine arteries via one endothelium-dependent and one endothelium-independent mechanism. Acta Physiol Scand 141: 281-282, 1991[ISI][Medline].

34.   Sato, K, Webb S, Tucker A, Rabinovitch M, O'Brien RF, McMurtry IF, and Stelzner TJ. Factors influencing the idiopathic development of pulmonary hypertension in the fawn hooded rat. Am Rev Respir Dis 145: 793-797, 1992[ISI][Medline].

35.   Sladek, M, Parker RA, Grogaard JB, and Sundell HW. Long-lasting effect of prolonged hypoxemia after birth on the immediate ventilatory response to changes in partial pressure of oxygen in young lambs. Pediatr Res 34: 821-828, 1993[ISI][Medline].

36.   Springall, DR, Collina G, Barer G, Suggett AJ, Bee D, and Polak JM. Increased intracellular levels of calcitonin gene-related peptide-like immunoreactivity in pulmonary endocrine cells of hypoxic rats. J Pathol 155: 259-167, 1988[ISI][Medline].

37.   Tjen-A-Looi, S, Ekman R, Kraiczi H, and Keith IM. Sensory CGRP depletion exacerbates hypoxia-induced pulmonary hypertension in rats. Regul Pept 74: 1-10, 1998[ISI][Medline].

38.   Tjen-A-Looi, S, Ekman R, Lippton H, Cary J, and Keith IM. CGRP and somatostatin modulate chronic hypoxic pulmonary hypertension. Am J Physiol Heart Circ Physiol 263: H681-H690, 1992[Abstract/Free Full Text].

39.   Tjen-A-Looi, S, Ekman R, Osborn J, and Keith IM. Pulmonary vascular pressure effects by endothelin-1 in normoxia and chronic hypoxia: a longitudinal study. Am J Physiol Heart Circ Physiol 271: H2246-H2253, 1996[Abstract/Free Full Text].

40.   Valdes-Dapena, M. The sudden death syndrome: pathologic findings. Clin Perinatol 19: 701-716, 1992[ISI][Medline].

41.   Van Rossum, D, Hanisch UK, and Quirion R. Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides, and their receptors. Neurosci Biobehav Rev 21: 649-678, 1997[ISI][Medline].

42.   Wegman, ME. Annual summary of vital statistics-1981. Pediatrics 70: 835-843, 1988[Abstract/Free Full Text].

43.   Wimalawansa, SJ. Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology and therapeutic potentials. Endocr Rev 17: 533-585, 1996[ISI][Medline].

44.   Youngson, C, Nurse C, Yeger H, and Cutz E. Oxygen sensing in airway chemoreceptors. Nature 365: 153-155, 1993[Medline].

Am J Physiol Heart Circ Physiol 279(4):H1571-H1578
0363-6135/00 $5.00 Copyright © 2000 the American Physiological Society


This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
Q. Zhao, Z. Liu, Z. Wang, C. Yang, J. Liu, and J. Lu
Effect of Prepro-Calcitonin Gene-Related Peptide Expressing Endothelial Progenitor Cells on Pulmonary Hypertension
Ann. Thorac. Surg., August 1, 2007; 84(2): 544 - 552.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. Kantores, P. J. McNamara, L. Teixeira, D. Engelberts, P. Murthy, B. P. Kavanagh, and R. P. Jankov
Therapeutic hypercapnia prevents chronic hypoxia-induced pulmonary hypertension in the newborn rat
Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L912 - L922.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
W. Deng, T. J. Bivalacqua, N. N. Chattergoon, J. R. Jeter Jr., and P. J. Kadowitz
Engineering Ex Vivo-Expanded Marrow Stromal Cells to Secrete Calcitonin Gene-Related Peptide Using Adenoviral Vector
Stem Cells, December 1, 2004; 22(7): 1279 - 1291.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
E. Villamor, C. G. A. Kessels, K. Ruijtenbeek, R. J. van Suylen, J. Belik, J. G. R. De Mey, and C. E. Blanco
Chronic in ovo hypoxia decreases pulmonary arterial contractile reactivity and induces biventricular cardiac enlargement in the chicken embryo
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2004; 287(3): R642 - R651.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
S. D. Brain and A. D. Grant
Vascular Actions of Calcitonin Gene-Related Peptide and Adrenomedullin
Physiol Rev, July 1, 2004; 84(3): 903 - 934.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
V. Hampl, J. Bibova, I. Ostadalova, V. Povysilova, and J. Herget
Gender differences in the long-term effects of perinatal hypoxia on pulmonary circulation in rats
Am J Physiol Lung Cell Mol Physiol, August 1, 2003; 285(2): L386 - L392.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
X. Qing and I. M. Keith
Targeted blocking of gene expression for CGRP receptors elevates pulmonary artery pressure in hypoxic rats
Am J Physiol Lung Cell Mol Physiol, July 1, 2003; 285(1): L86 - L96.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keith, I. M.
Right arrow Articles by Ekman, R.
Right arrow